Evidence map›Paper›PMID 37764763›Full record

ArticleNutrients2023

Latent TB Infection, Vitamin D Status and COVID-19 Severity in Mongolian Patients.

Davaasambuu Ganmaa, Tserendorj Chinbayar, Polyna Khudaykov, Erdenebileg Nasantogtoh, Sukhbaatar Ariunbuyan, Tserenkhuu Enkhtsetseg, Ganbold Sarangua, Andrew Chan, Dalkh Tserendagva

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Davaasambuu GanmaaChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Tserendorj ChinbayarNational Center for Communicable Disease, Ulaanbaatar 13335, Mongolia.
Polyna KhudaykovSage Therapeutics, Cambridge, MA 02142, USA.
Erdenebileg NasantogtohNational Center for Maternal and Child Health, Ulaanbaatar 16060, Mongolia.ORCID 0000-0002-0573-9424
Sukhbaatar AriunbuyanDivision of Oral and Maxillofacial Oncology and Surgical Sciences, Graduate School of Dentistry, Tohoku University, Sendai 980-8575, Japan.
Tserenkhuu EnkhtsetsegMongolian Health Initiative (MHI), Ulaanbaatar 14210, Mongolia.
Ganbold SaranguaNational Center for Communicable Disease, Ulaanbaatar 13335, Mongolia.
Andrew ChanDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Dalkh TserendagvaInternational School of Mongolian Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.
National Center for Communicable Diseases · MNBrigham and Women's Hospital · USMongolian National University · MNSage Therapeutics (United States) · USTohoku University · JP

Funding

This work was sponsored by an anonymous foundation based in the United Kingdom. No grant nmbr
6 · The paper itself

Abstract

We aimed to determine potential risk factors for COVID-19 severity including serum vitamin D levels and latent TB infection among Mongolian inpatients diagnosed with COVID-19, and to study the effects of disease complications and treatment outcomes. This study included patients admitted to the Mongolian National Center for Communicable Disease, a main referral center for infectious disease in Mongolia, with COVID-19 ascertained by a positive PCR test. Patients' demographic, clinical, and laboratory data were analyzed. Of the 270 patients enrolled, 125 (46%) had mild-to-moderate illness, 86 (32%) had severe illness, and 59 (22%) had critical illness. Ten (91%) of the 11 patients who had active TB were hospitalized with severe or critical COVID-19, suggesting that they had a higher risk of falling into the severe category (OR = 10.6 [1.2; 92.0] 95% CI). Severe vitamin D deficiency (25(OH)D < 10 ng/mL) was present in 32% of the patients, but was not significantly associated with the severity of illness (

Indexed as

COVID-19Latent TuberculosisAnimalsCOVID-19 VaccinesFemaleGerbillinaeHumansMaleVitamin DVitaminsCOVID-19 VaccinesVitamin DVitaminsBCG vaccinationCOVID-19 severityMongoliatuberculosisvitamin D

Identifiers

PMID37764763
PMCPMC10536319
OpenAlexW4386782424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.